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Abstract
Priapism is a urological emergency that results in a penile or clitoral engorgement, having several triggers by the use of
medications, including psychiatric drugs, such as antipsychotics and antidepressants. The most common priapism
presentation is the ischemic type that can result in the fibrosis of corporus cavernosus, with a significant risk of persistent erectile
dysfunction. It is believed that, in the case of antipsychotic use, priapism is mediated by an imbalance in alpha-1-adrenergic
blocking,with large variation affinity for alpha-1-adrenergic receptors amongantipsychotics. This case report contributes to the
studyof this rare but severe side effect. Priapismcan limit both treatment adherence and the reproductive future of our patients.
We describe a case report of a patient with a delusional hypochondriac syndrome who had multiple priapism episodes using
clozapine 50 mg/daily. In conclusion, we make brief comments on priapism management, a hard clinical dilemma.
INTRODUCTION
Priapism is defined as an engorgement of penis or clitoris, usually
painful and prolonged (e.g. 3–4 h) [1, 2], unrelated to sexual
stimulus or desire. It is a urologic emergency and there are sev-
eral etiologies that require substantial differential diagnosis
from occlusive vessel diseases to perineal metastatic implants.
Among different triggers, priapism secondary to drugs owns a
great relevance, such as cocaine, marijuana and alcohol [3]. Psy-
chotropic medications such as antidepressants and antipsycho-
tics can contribute to such idiosyncratic events [4]. Apart from
psychotropics, other medications may cause a prolonged penile
erection, such as anticoagulants, antihypertensives and intraca-
vernosalmedicines. Antipsychotics are responsible for about half
of the venous priapism cases triggered by pills [5].
Although priapism may be considered a rare adverse event,
such urologic emergency requires agility on itsmanagement. De-
layed treatmentmay culminate in persistent erectile dysfunction
from 30 to 90% patients [6].
Medication-induced priapism is usually ischemic, due to im-
balance in alpha-1-adrenoreceptors (A1As), inducing intracaver-
nosal blood stasis. The change in penile blood flow may worsen
due to pathways related to nitric oxide, culminating in a vicious
circle that is only broken by a surgical intervention for withdraw-
ing the blood, by aspiration, surgical shunting or by pharmaco-
logically injecting A1A agonists to reduce local acidosis and
prevent ischemia, avoiding penile fibrosis [5, 6]. The antipsychot-
ic A1A receptor's affinity is variable and the occurrence of priap-
ism is considered as an idiosyncratic reaction, with poor or no
dose-dependent and time-dependent correlations [7].
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Many reports show that priapism can happen due to typical
and atypical intake of antipsychotics, related to therapeutic use
or overdose (suicide attempt) [4]. Among typical drugs, there
are cases associatedwith the use of the chlorpromazine, levome-
promazine, haloperidol [5, 8] and zuclopentixol [5]. Among atyp-
ical antipsychotics are ziprasidone, risperidone, clozapine [8, 9],
quetiapine [4, 5, 7, 8, 10], aripiprazole [7] and olanzapine [7, 9].
No reports associated with amisulpride and pipothiazine were
found [5].
Motivated by the abovementioned case report, we decided to
discuss this rare adverse effect—a tough and unexpected clinical
and therapeutic dilemma that could possibly harm both treat-
ment adhesion and patients’ reproductive future. This case re-
port was conducted, following the institutional ethical rules.
Informed consent of the patient was taken before the case was
submitted to publishing considerations.
CASE REPORT
V.S.N., 31 years old, who discontinued high school education, and
is an ex-bricklayer assistant, protestant, cared by his sister. He re-
turned to the psychiatric outpatient ambulatory in 2013, where he
had been followed from 1998 to 2010 before moving to another
town. He was readmitted to our service after repeatedly visiting
the hospital’s emergency department with somatic complaints
without clinical findings after several investigations: ‘I have a se-
vere inflammation in my bladder, my kidneys are crumbling to
dust, I feel a stone on the left side, everything’s fully choked inside
my body, my skin smells like putrefied meat’.
Symptoms began 15 years ago accompanied by social isola-
tion, anhedonia, paranoia, avolition, excessive and bizarre som-
atic concerns, with kinesthetic hallucinations, and loss of labor
interests culminating in a significant hypochondriac existence.
Without disease insights, he peregrinated too many hospitals
seeking for ‘physicians that would cure the disease that is
going to kill me’.
He had never used psychoactive abuse substances, and had no
hemoglobinopathies and pelvic injuries. He had already used
haloperidol 10 mg/daily irregularly for a couple of months but de-
veloped dystonia. During daily irregular risperidone 4 mg intake,
his improvement was negligible and he maintained his negative
symptoms, such as delusions and kinesthetic hallucinations. His
best therapeutic responsewas observed during irregular clozapine
400 mg/daily for 8 years, with improvement of delusional hypo-
chondriac symptoms and slightly persistent negative symptoms
(isolation and flatted affection). He stopped clozapine at 2010
when he hadmoved to a small town in order to live with another
sister and lost ambulatory follow-up. There are no priapism re-
ports on his medical records during his treatment.
After failure on ambulatory follow-up at 2013, hewas readmit-
ted to psychiatry care treatment at the University Hospital as part
of his therapeutic project that proposed clozapine reintroduction.
At that time, the patient was not taking any medications. He at
that time had the same delusional hypochondriac symptoms
and no insight: ‘I feel my flesh stink; the cancer is going to kill
me, everything is fully choked inside myself’. He complained of
abdominal and suprapubic pain at the first week at the psychiatric
ward. He restricted his feeding saying ‘everything in his body was
inflamed’. Physical and laboratory examinationswerewithout ab-
normalities, including abdominal ultrasound, upper endoscopic
studies, electrolytes, blood tests and serologies.
On his fifth hospitalization day, while he was using clozapine
50 mg/daily, he hadhis first priapismepisodewith little pain last-
ing 5 h. This episode resolved after rigorous hydration. The
following day, he suffered another similar event, nevertheless
lasting shorter. The clinical staff decided to suspend clozapine
and observe. After 2 days, another episode occurred, for a shorter
period of time. He still complained of perineal and suprapubic
pain, but now relating the priapism events with delusional
ideas: ‘the disease is worsening, testicles are decreasing, my
penis is choking, so as my kidneys and bladder’. We interpreted
that ‘residual priapism’ was linked to the possible presence of
clozapine active metabolites in the serum of that patient. Unfor-
tunately, at that time, the access to clozapine blood level moni-
toring was not available in the hospital.
After priapism episodes, one of his family members told us
that the patient had already had previous priapism episodes dur-
ing clozapine irregular intake (∼100–400 mg daily) between 2002
and 2010. Based on the hypothesis that priapism tendency with
clozapine intakewas high in that case, and excluded the possibil-
ity of multiple antipsychotics interactions, as wemaintained the
patient using only one antipsychotic by time,we decided to intro-
duce and observe olanzapine intake, until the actual 20 mg daily.
That decision was based on the fact that olanzapine may have
lower affinity to A1A receptor [5, 7, 11], possibly linked to the anti-
psychotic-induced priapism pathophysiology. Since then, during
the rest of incare and aftercare (about 1 year) follow-up treat-
ment, no more priapism episodes were observed.
DISCUSSION
Alpha-1-Adrenergic receptor antagonism may lead to arteriole
dilation that causes blockade of venous drainage due to an in-
crease of the intracavernosal pressure, and triggers venous stasis
because of venous collapse. Anti-erection mechanism gets da-
maged and penile or clitorial engorgement is perpetuated [5].
A recent case report suggests that some patients may have a
biological and/or genetic tendency to develop drug-induced pri-
apism [12]. Maybe that is the case of a patient, possibly with clo-
zapine. We also argue that further studies on the connection
between biological tendencies and drug-induced priapism
should be investigated [12].
Penile detumescence or flaccidity is a process mediated by the
sympathetic autonomic nervous system; intracavernosal A1A an-
tagonism inhibits it and therefore increases the time of penile
erection. Antipsychotics have different profiles of A1A receptor
affinity [13]. For this purpose, study results are used, as of the
Richelson et al. [5, 11], which are made in vitro, then compared
with values among various antipsychotics. Regarding that literature
information, there are more therapeutic possibilities for a safe
choice to patients with more risk of priapism occurrence that
need to use antipsychotics.
During follow-up of patients in the use of antipsychotic med-
ications, clinicians should pay close attention to risk factors to
priapism that are in the sequence list [12]. As soon as it happens,
it is essential to make a meticulous investigation to find out the
possible etiologies: hemopathies, hepatic injuries, metabolic al-
terations, psychoactive substance use (mainly, cocaine), perineal
neoplasia or trauma and drugs interaction (including anti-
psychotic combinations).
This case report has the purpose to discuss this rare adverse
event, but very severe, mainly between clinicians and psychia-
trists who deal with antipsychotics drugs [14].
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